These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16616724)

  • 21. Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1.
    Ivins S; Lammerts van Beuren K; Roberts C; James C; Lindsay E; Baldini A; Ataliotis P; Scambler PJ
    Dev Biol; 2005 Sep; 285(2):554-69. PubMed ID: 16109395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.
    Arinami T
    J Hum Genet; 2006; 51(12):1037-1045. PubMed ID: 16969581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
    Guo T; McDonald-McGinn D; Blonska A; Shanske A; Bassett AS; Chow E; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon TJ; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Goldmuntz E; Zackai E; Wang T; Shprintzen R; Emanuel B; Morrow B;
    Hum Mutat; 2011 Nov; 32(11):1278-89. PubMed ID: 21796729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome.
    Driscoll DA
    Methods Mol Med; 2006; 126():43-55. PubMed ID: 16930005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring a neurogenic basis of velopharyngeal dysfunction in Tbx1 mutant mice: no difference in volumes of the nucleus ambiguus.
    Spruijt NE; Rana MS; Christoffels VM; Mink van der Molen AB
    Int J Pediatr Otorhinolaryngol; 2013 Jun; 77(6):1002-7. PubMed ID: 23642587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion.
    Xu H; Cerrato F; Baldini A
    Development; 2005 Oct; 132(19):4387-95. PubMed ID: 16141220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomal microdeletions: dissecting del22q11 syndrome.
    Lindsay EA
    Nat Rev Genet; 2001 Nov; 2(11):858-68. PubMed ID: 11715041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 22q11 deletion syndrome: a review of some developmental biology aspects of the cardiovascular system.
    Restivo A; Sarkozy A; Digilio MC; Dallapiccola B; Marino B
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):77-85. PubMed ID: 16645366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion 22q11: spectrum of associated disorders.
    Hay BN
    Semin Pediatr Neurol; 2007 Sep; 14(3):136-9. PubMed ID: 17980310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes.
    Taddei I; Morishima M; Huynh T; Lindsay EA
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11428-31. PubMed ID: 11562466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic changes in gene expression profiles of 22q11 and related orthologous genes during mouse development.
    Amati F; Biancolella M; Farcomeni A; Giallonardi S; Bueno S; Minella D; Vecchione L; Chillemi G; Desideri A; Novelli G
    Gene; 2007 Apr; 391(1-2):91-102. PubMed ID: 17321697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 22q11 deletion: DiGeorge and velocardiofacial syndromes and the role of TBX1.
    Papangeli I; Scambler P
    Wiley Interdiscip Rev Dev Biol; 2013; 2(3):393-403. PubMed ID: 23799583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome.
    Prescott K; Ivins S; Hubank M; Lindsay E; Baldini A; Scambler P
    Hum Genet; 2005 May; 116(6):486-96. PubMed ID: 15778864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
    Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D
    Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Source monitoring for actions in adolescents with 22q11.2 deletion syndrome (22q11DS).
    Debbané M; Van der Linden M; Glaser B; Eliez S
    Psychol Med; 2008 Jun; 38(6):811-20. PubMed ID: 18005497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The del22q11.2 candidate gene Tbx1 controls regional outflow tract identity and coronary artery patterning.
    Théveniau-Ruissy M; Dandonneau M; Mesbah K; Ghez O; Mattei MG; Miquerol L; Kelly RG
    Circ Res; 2008 Jul; 103(2):142-8. PubMed ID: 18583714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebral polymicrogyria and 22q11 deletion syndrome].
    Arriola-Pereda G; Verdú-Pérez A; de Castro-De Castro P
    Rev Neurol; 2009 Feb 16-28; 48(4):188-90. PubMed ID: 19226486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing models of DiGeorge syndrome.
    Epstein JA
    Trends Genet; 2001 Oct; 17(10):S13-7. PubMed ID: 11585671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome.
    Meechan DW; Tucker ES; Maynard TM; LaMantia AS
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16434-45. PubMed ID: 19805316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study on the occurrence of the deletion 22q11.2 in patients affected with a psychiatric disease].
    Pawłowska B; Tomankiewicz-Zawadzka A; Ilnicka A; Bogdanowicz J; Wciórka J; Szafrański T; Woźniak P; Meder J; Szaniawska-Bartnicka A; Zdzienicka E; Szirkowiec W; Zaremba J
    Psychiatr Pol; 2007; 41(2):251-60. PubMed ID: 17598434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.